Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus
ABSTRACT Encephalomyocarditis virus (EMCV) is an animal pathogen and an important model organism, whose receptor requirements are poorly understood. Here, we employed a genome-wide haploid genetic screen to identify novel EMCV host factors. In addition to the previously described picornavirus recept...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01a74b9ee28949e48a4b505a3ba38c76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:01a74b9ee28949e48a4b505a3ba38c76 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:01a74b9ee28949e48a4b505a3ba38c762021-11-15T16:22:08ZIdentification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus10.1128/mBio.01780-192150-7511https://doaj.org/article/01a74b9ee28949e48a4b505a3ba38c762019-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01780-19https://doaj.org/toc/2150-7511ABSTRACT Encephalomyocarditis virus (EMCV) is an animal pathogen and an important model organism, whose receptor requirements are poorly understood. Here, we employed a genome-wide haploid genetic screen to identify novel EMCV host factors. In addition to the previously described picornavirus receptors sialic acid and glycosaminoglycans, this screen unveiled important new host factors for EMCV. These factors include components of the fibroblast growth factor (FGF) signaling pathway, such as the potential receptors FGFR1 and ADAM9, a cell-surface metalloproteinase. By employing various knockout cells, we confirmed the importance of the identified host factors for EMCV infection. The largest reduction in infection efficiency was observed in cells lacking ADAM9. Pharmacological inhibition of the metalloproteinase activity of ADAM9 did not affect virus infection. Moreover, reconstitution of inactive ADAM9 in knockout cells restored susceptibility to EMCV, pointing to a proteinase-independent role of ADAM9 in mediating EMCV infection. Using neutralization assays with ADAM9-specific antiserum and soluble receptor proteins, we provided evidence for a role of ADAM9 in EMCV entry. Finally, binding assays showed that ADAM9 facilitates attachment of EMCV to the cell surface. Together, our findings reveal a role for ADAM9 as a novel receptor or cofactor for EMCV. IMPORTANCE EMCV is an animal pathogen that causes acute viral infections, usually myocarditis or encephalitis. It is thought to circulate mainly among rodents, from which it is occasionally transmitted to other animal species, including humans. EMCV causes fatal outbreaks of myocarditis and encephalitis in pig farms and zoos, making it an important veterinary pathogen. Although EMCV has been widely used as a model to study mechanisms of viral disease in mice, little is known about its entry mechanism. Here, we employ a haploid genetic screen for EMCV host factors and identify an essential role for ADAM9 in EMCV entry.Jim BaggenHendrik Jan ThibautDaniel L. HurdissMaryam WahediCaleb D. MarceauArno L. W. van VlietJan E. CaretteFrank J. M. van KuppeveldAmerican Society for Microbiologyarticledisintegrin and metalloproteinase domain-containing protein 9 (ADAM9)encephalomyocarditis virushaploid genetic screenMicrobiologyQR1-502ENmBio, Vol 10, Iss 4 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
disintegrin and metalloproteinase domain-containing protein 9 (ADAM9) encephalomyocarditis virus haploid genetic screen Microbiology QR1-502 |
spellingShingle |
disintegrin and metalloproteinase domain-containing protein 9 (ADAM9) encephalomyocarditis virus haploid genetic screen Microbiology QR1-502 Jim Baggen Hendrik Jan Thibaut Daniel L. Hurdiss Maryam Wahedi Caleb D. Marceau Arno L. W. van Vliet Jan E. Carette Frank J. M. van Kuppeveld Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus |
description |
ABSTRACT Encephalomyocarditis virus (EMCV) is an animal pathogen and an important model organism, whose receptor requirements are poorly understood. Here, we employed a genome-wide haploid genetic screen to identify novel EMCV host factors. In addition to the previously described picornavirus receptors sialic acid and glycosaminoglycans, this screen unveiled important new host factors for EMCV. These factors include components of the fibroblast growth factor (FGF) signaling pathway, such as the potential receptors FGFR1 and ADAM9, a cell-surface metalloproteinase. By employing various knockout cells, we confirmed the importance of the identified host factors for EMCV infection. The largest reduction in infection efficiency was observed in cells lacking ADAM9. Pharmacological inhibition of the metalloproteinase activity of ADAM9 did not affect virus infection. Moreover, reconstitution of inactive ADAM9 in knockout cells restored susceptibility to EMCV, pointing to a proteinase-independent role of ADAM9 in mediating EMCV infection. Using neutralization assays with ADAM9-specific antiserum and soluble receptor proteins, we provided evidence for a role of ADAM9 in EMCV entry. Finally, binding assays showed that ADAM9 facilitates attachment of EMCV to the cell surface. Together, our findings reveal a role for ADAM9 as a novel receptor or cofactor for EMCV. IMPORTANCE EMCV is an animal pathogen that causes acute viral infections, usually myocarditis or encephalitis. It is thought to circulate mainly among rodents, from which it is occasionally transmitted to other animal species, including humans. EMCV causes fatal outbreaks of myocarditis and encephalitis in pig farms and zoos, making it an important veterinary pathogen. Although EMCV has been widely used as a model to study mechanisms of viral disease in mice, little is known about its entry mechanism. Here, we employ a haploid genetic screen for EMCV host factors and identify an essential role for ADAM9 in EMCV entry. |
format |
article |
author |
Jim Baggen Hendrik Jan Thibaut Daniel L. Hurdiss Maryam Wahedi Caleb D. Marceau Arno L. W. van Vliet Jan E. Carette Frank J. M. van Kuppeveld |
author_facet |
Jim Baggen Hendrik Jan Thibaut Daniel L. Hurdiss Maryam Wahedi Caleb D. Marceau Arno L. W. van Vliet Jan E. Carette Frank J. M. van Kuppeveld |
author_sort |
Jim Baggen |
title |
Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus |
title_short |
Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus |
title_full |
Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus |
title_fullStr |
Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus |
title_full_unstemmed |
Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus |
title_sort |
identification of the cell-surface protease adam9 as an entry factor for encephalomyocarditis virus |
publisher |
American Society for Microbiology |
publishDate |
2019 |
url |
https://doaj.org/article/01a74b9ee28949e48a4b505a3ba38c76 |
work_keys_str_mv |
AT jimbaggen identificationofthecellsurfaceproteaseadam9asanentryfactorforencephalomyocarditisvirus AT hendrikjanthibaut identificationofthecellsurfaceproteaseadam9asanentryfactorforencephalomyocarditisvirus AT daniellhurdiss identificationofthecellsurfaceproteaseadam9asanentryfactorforencephalomyocarditisvirus AT maryamwahedi identificationofthecellsurfaceproteaseadam9asanentryfactorforencephalomyocarditisvirus AT calebdmarceau identificationofthecellsurfaceproteaseadam9asanentryfactorforencephalomyocarditisvirus AT arnolwvanvliet identificationofthecellsurfaceproteaseadam9asanentryfactorforencephalomyocarditisvirus AT janecarette identificationofthecellsurfaceproteaseadam9asanentryfactorforencephalomyocarditisvirus AT frankjmvankuppeveld identificationofthecellsurfaceproteaseadam9asanentryfactorforencephalomyocarditisvirus |
_version_ |
1718426884768792576 |